Patient | Follow-up (Months) | Preop BCVA | Postop BCVA | Preop IOP | Postop highest IOP | Postop IOP | IOP % Reduction | Number of preop drugs | Number of postop drugs | Complications | SEC operation |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 36 | 1MCF | 0.3 | 50 | 34 | 16 | 0.68 | 4 | 0 | Tube occlusion by iris, SEC CAT | IV Lucentis, PHACO, tube repositioning |
2 | 36 | 1MCF | 0.1 | 34 | 26 | 18 | 0.47 | 4 | 3 | Hyphema | IV Lucentis, PHACO, AC Lavage |
3 | 16 | 1MCF | 0.2 | 34 | 22 | 12 | 0.65 | 5 | 2 | None | 0 |
4 | 13 | HM | HM | 34 | 17 | 17 | 0.5 | 3 | 0 | None | 0 |
5 | 12 | p+ | HM | 54 | 17 | 10 | 0.81 | 4 | 0 | None | 0 |
6 | 27 | 1MCF | 0.3 | 52 | 22 | 17 | 0.67 | 5 | 3 | IVH | IV Lucentis, PPV |
7 | 27 | HM | 0.05 | 54 | 18 | 10 | 0.81 | 5 | 0 | IVH, hyphema | AC Lavage, IV Lucentis, PPV |
8 | 20 | p+ | p+ | 40 | 30 | 19 | 0.53 | 4 | 0 | Tenon’s cyst | Cyst drainage, cystectomy |
9 | 12 | 0.4 | 0.6 | 31 | 10 | 8 | 0.74 | 3 | 0 | None | 0 |
10 | 12 | NLP | NLP | 57 | 24 | 17 | 0.7 | 5 | 3 | None | 0 |
11 | 24 | NLP | NLP | 50 | 30 | 16 | 0.68 | 5 | 0 | None | Diode CPC |
12 | 23 | HM | 0.05 | 38 | 28 | 10 | 0.74 | 3 | 0 | SEC CAT | Silicon extraction, PPV |
13 | 24 | NLP | P- | 32 | 28 | 17 | 0.47 | 3 | 2 | Tenon’s cyst | Cyst drainage, cystectomy |
14 | 27 | 5MCF | 5MCF | 45 | 24 | 15 | 0.67 | 6 | 4 | None | 0 |
15 | 36 | 0.16 | 0.6 | 48 | 26 | 16 | 0.67 | 6 | 2 | None | 0 |
16 | 15 | NLP | NLP | 51 | 25 | 12 | 0.76 | 4 | 0 | Choroidal detachment | 0 |
17 | 12 | NLP | NLP | 51 | 22 | 18 | 0.65 | 3 | 2 | None | 0 |
18 | 18 | 1MCF | 1MCF | 62 | 35 | 20 | 0.68 | 4 | 1 | HSV uveitic activation and tube occlusion | 0 |
19 | 24 | 2MCF | 2MCF | 50 | 10 | 10 | 0.8 | 2 | 0 | None | 0 |
20 | 27 | NLP | NLP | 38 | 28 | 15 | 0.61 | 4 | 2 | None | 0 |
21 | 24 | NLP | NLP | 55 | 12 | 10 | 0.82 | 4 | 0 | None | 0 |
22 | 18 | 0.2 | 0.05 | 57 | 28 | 20 | 0.65 | 5 | 0 | Tube occlusion with silicon oil | 0 |
23 | 18 | 0.05 | HM | 38 | 24 | 9 | 0.76 | 6 | 0 | Suprachoroidal hemorrage, coroidal detachment | PPV |
24 | 22 | 0.7 | 1 | 26 | 17 | 13 | 0.5 | 4 | 0 | None | 0 |
25 | 22 | 0.5 | 0.7 | 38 | 16 | 11 | 0.71 | 4 | 0 | None | 0 |
26 | 14 | 0.05 | 0.1 | 32 | 18 | 9 | 0.72 | 4 | 0 | None | 0 |
27 | 27 | HM | HM | 40 | 20 | 18 | 0.55 | 2 | 0 | None | 0 |